Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the association between systemic inflammation measured during midlife and 20-year cognitive decline. METHODS: Within the Atherosclerosis Risk in Communities cohort study, inflammatory biomarkers were measured during middle adulthood. We created an inflammation composite score using 4 blood biomarkers measured at visit 1 (fibrinogen, white blood cell count, von Willebrand factor, and factor VIII); we measured C-reactive protein (CRP) at visit 2. Cognition was assessed over 3 visits spanning 20 years using measures of memory, executive function, and language. RESULTS: A total of 12,336 participants (baseline age 56.8 [5.7], 21% black, 56% women) were included. After adjusting for demographic variables, vascular risk factors, and comorbidities, each standard deviation (SD) increase in midlife inflammation composite score was associated with an additional 20-year decline of -0.035 SD (95% confidence interval: -0.062 to -0.007) on the cognitive composite score. We found a similar association between each SD increase in midlife CRP level and additional 20-year cognitive decline (-0.038 SD, 95% confidence interval: -0.057 to -0.019). Participants with a midlife inflammation composite score in the top quartile had a 7.8% steeper cognitive decline, compared to participants in the lowest quartile; CRP in the top quartile was associated with an 11.6% steeper cognitive decline. In cognitive domain-specific analyses, elevated midlife inflammatory markers were most consistently associated with declines in memory. Results were similar after adjusting for attrition using inverse probability weighting. CONCLUSIONS: Our findings highlight what may be an early pathogenic role for systemic inflammation as a driver of cognitive decline in the decades leading up to older adulthood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been reported that individuals with higher levels of inflammatory proteins in the blood during midlife (decades before the typical age of dementia symptom onset) are at increased risk for developing neurodegenerative disease.92”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [92]
In the citing paper
“According to Walker K. et al., elevated inflammatory markers in middle adulthood resulted in significant cognitive decline after 20 years [74].”
From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [74]
Citations
Cites
(1989) · PubMed · Cited by 3,139
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 2,924
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,159 · cited 1×
“High-density lipoprotein (HDL) cholesterol was measured following the precipitation of non-HDL lipoprotein.(16) Hypertension was defined as systolic blood pressure >140 mm Hg, diastolic blood pressure >90 mm Hg, or use of hypertensive medication.”
MethodThe metabolic syndrome, inflammation, and risk of cognitive decline
Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025
Siedel, J., Hägele, E. O., Ziegenhorn, J., & Wahlefeld, A. W. (1983) · Clinical Chemistry · doi:10.1093/clinchem/29.6.1075 · Cited by 942 · cited 1×
“The enzymatic method was used to measure total cholesterol.(15) High-density lipoprotein (HDL) cholesterol was measured following the precipitation of non-HDL lipoprotein.”
MethodEarly inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710 · cited 2×
“Our findings are supported by those from the Honolulu-Asia Aging Study, which demonstrated that individuals with higher levels of CRP during midlife are at greater risk of dementia 25 years later.(25) Given that neuropathologic processes associated with dementia, such as β-amyloid deposition, are believed to begin dur…”
BackgroundResultInterleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging
Weaver, J. D., Huang, M.-H., Albert, M., Harris, T., Rowe, J. W., & Seeman, T. E. (2002) · Neurology · doi:10.1212/wnl.59.3.371 · Cited by 536
Lifespan CognitionMechanisms of Change
Bialystok, E., & Craik, F. I. M. (2006) · doi:10.1093/acprof:oso/9780195169539.001.0001 · Cited by 525
Gottesman, R. F., Schneider, A. L. C., Albert, M., Alonso, A., Bandeen-Roche, K., Coker, L., Coresh, J., Knopman, D., Power, M. C., Rawlings, A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1646 · Cited by 474
Self-citation
Research works printed but not linked: 2
- Bialystok E, Craik FIM. Lifespan Cognition: Mechanisms of Change. Oxford, UK: Oxford University Press; 2012.
- 10.3758/s13423-015-0910-8 · DOI
Cited by
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
“It has been reported that individuals with higher levels of inflammatory proteins in the blood during midlife (decades before the typical age of dementia symptom onset) are at increased risk for developing neurodegenerative disease.(92) Similarly, elevations in inflammatory proteins during midlife have been associated…”
BackgroundThe ARIC (Atherosclerosis Risk In Communities) Study
Wright, J. D., Folsom, A. R., Coresh, J., Sharrett, A. R., Couper, D., Wagenknecht, L. E., Mosley, T. H., Ballantyne, C. M., Boerwinkle, E. A., Rosamond, W. D., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.035 · Cited by 552
Self-citationPeripheral and central immune system crosstalk in Alzheimer disease — a research prospectus
Bettcher, B. M., Tansey, M. G., Dorothée, G., & Heneka, M. T. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00549-x · Cited by 427
Neuroprotective effect of SGLT2 inhibitors.
Pawlos, A., Broncel, M., Woźniak, E., & Gorzelak-Pabiś, P. (2021) · Molecules · doi:10.3390/molecules26237213 · Cited by 304
“, elevated inflammatory markers in middle adulthood resulted in significant cognitive decline after 20 years [74].”
BackgroundInflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study
Zhang, B., Wang, H. E., Bai, Y.-M., Tsai, S.-J., Su, T.-P., Chen, T.-J., Wang, Y.-P., & Chen, M.-H. (2021) · Gut · doi:10.1136/gutjnl-2020-320789 · Cited by 292
Metadata
- Authors
- Walker, K. A., Gottesman, R. F., Wu, A., Knopman, D. S., Gross, A. L., Mosley, T. H., Selvin, E., & Windham, B. G.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Neurology
- Published
- 2019-03-12
- Volume
- 92
- Issue
- 11
- Pages
- e1256-e1267
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC6511107
- OpenAlex
- W2911533792
- Cited by
- 282
- References
- 33
- Citations by year
- 2026: 42 · 2025: 39 · 2024: 44 · 2023: 31 · 2022: 46 · 2021: 39 · 2020: 30 · 2019: 10
- FWCI
- 24.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01hl096899-08, 5u01hl096902-08)
- National Institute on Aging (K24AG052573, K01AG050699, T32AG027668)
- National Heart, Lung, and Blood Institute (HHSN268201700001I, HHSN268201700005C, HHSN268201700003I, U01HL096814, U01-HL-096899, HHSN268201700005I, U01-HL-096902, HHSN268201700001C, U01HL096917, HHSN268201700002I, HHSN268201700003C, HHSN268201700002C, R01HL070825, U01HL096812)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK106414, R01DK089174)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- systemic inflammation, cognitive decline, midlife, C-reactive protein, inflammatory markers, fibrinogen, von Willebrand factor, factor VIII, white blood cell count, memory decline, executive function, language, Atherosclerosis Risk in Communities Study
- MeSH terms
- Aged, Aged, 80 and over, C-Reactive Protein, Cognition, Factor VIII, Female, Fibrinogen, Humans, Inflammation, Language, Leukocyte Count, Longitudinal Studies, Male, Memory, Middle Aged, von Willebrand Factor, Cohort Studies, Executive Function, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study. https://app.cochat.ai/papers/10.1212/wnl.0000000000007094
- The paper
- Walker, K. A., Gottesman, R. F., Wu, A., Knopman, D. S., Gross, A. L., Mosley, T. H., Selvin, E., & Windham, B. G. (2019). Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study. Neurology. https://doi.org/10.1212/wnl.0000000000007094
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.